Recombinant Fowlpox-gp100p209
A viral vaccine comprised of a recombinant fowlpox vector construct encoding a modified epitope of the melanoma antigen glycoprotein 100 (gp100), ES-2092M(gp100), containing an endoplasmic reticulum signal sequence targeted to the endoplasmic reticulum apparatus. Vaccination with recombinant fowlpox-gp100p209 vaccine may stimulate the host immune system more efficiently to mount a cytotoxic T lymphocyte response against tumor cells expressing the gp100 antigen. [ ]
Term info
Recombinant Fowlpox-gp100p209
- Recombinant Fowlpox-gp100p209
- rF-gp100p209
http://purl.obolibrary.org/obo/NCIT_C2386
Recombinant_Fowlpox-gp100p209
702139
Recombinant Fowlpox-gp100p209
Virus, Pharmacologic Substance
C1514778
C2806
Term relations
- Fowlpox Virus Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Gene Regulation Process
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation